COMPARISON OF TRANSFORAMINAL EPIDURAL INJECTION OF DEXAMETHASONE AND METHYLPREDNISOLONE IN REDUCING LOW BACK PAIN AND DISABILITY IN PROLAPSED LUMBAR INTERVERTEBRAL DISC

COMPARISON OF TRANSFORAMINAL EPIDURAL INJECTION OF DEXAMETHASONE AND METHYLPREDNISOLONE IN REDUCING LOW BACK PAIN AND DISABILITY IN PROLAPSED LUMBAR INTERVERTEBRAL DISC AMONGST THE INDIGENOUS POPULATION OF MANIPUR, INDIA: A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021898

Enrollment

Registered

2019-11-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G544- Lumbosacral root disorders, not elsewhere classified

Interventions

Intervention1: Fluoroscopic guided transforaminal epidural steroid injection of dexamethasone in prolapsed lumbar intervertebral disc: Patient was placed in a prone position and using an ipsilateral

Eligibility

Inclusion criteria

Inclusion criteria: Patients with back pain due to prolapsed lumbar disc L4-L5 and L5-S1, confirmed by MRI (Grade II and III), Pain severity with minimum score of 5 based on 10 point scale VAS (Visual Analogue Scale),Pain duration

Exclusion criteria

Exclusion criteria: 1. Cauda equina syndrome 2. Mental or physical condition that would invalidate evaluation results 3. Prior lumbar surgery at any level 4. Patient is scheduled to have more than one level of steroid injection 5. Pregnancy 6. Systemic or local infection at site of injection 7. Known allergy to corticosteroids, contrast dye or anesthetics 8. History of any malignancy (including hematologic and non-hematologic malignancies) 9. Bleeding disorders 10. Uncontrolled diabetes mellitus/ hypertension 11. Received any spinal injection in the past 3 months 12. Subjects who refused to sign informed consent

Design outcomes

Primary

Measure	Time frame
1. Visual Analogue Scale(VAS) 2. Oswestry Disability Index(ODI) Timepoint: 1 week, 1 month, 6 months	—

Secondary

Measure	Time frame
SLRTTimepoint: 1 week, 1 month, 6 months	—

Countries

India

Contacts

Public ContactKanti Rajkumari

Regional Institute of Medical Sciences

joyakoijam2@yahoo.com9436026960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026